This inventor holds 1 USPTO granted patent. Top assignee: The City University of New York. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: Malgorzata Frik: Innovator in Cancer Therapy
Introduction
Malgorzata Frik is a notable inventor based in Glendale, NY (US). She has made significant contributions to the field of cancer therapy through her innovative research and development of new compounds.
Latest Patents
Malgorzata Frik holds a patent for "Arene ruthenium (II) derivatives containing iminophosphorane ligands and their use in cancer therapy." This patent describes a method for providing therapeutic benefits to subjects with cancer. The method involves administering a compound that includes an arene ruthenium (II) compound with an iminophosphorane ligand to the subject. This innovative approach has the potential to improve cancer treatment outcomes.
Career Highlights
Malgorzata Frik is affiliated with The City University of New York, where she continues her research and development efforts. Her work is characterized by a commitment to advancing cancer therapy through innovative chemical compounds.
Collaborations
Malgorzata has collaborated with esteemed colleagues, including Benelita T Elie and Maria Contel. These collaborations have further enriched her research and contributed to the advancement of cancer treatment methodologies.
Conclusion
Malgorzata Frik's contributions to cancer therapy through her innovative patents and collaborative efforts highlight her role as a leading inventor in the field. Her work continues to inspire advancements in medical research and treatment options.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile